These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 18474271)

  • 1. The role of leukocyte-generated oxidants in left ventricular remodeling.
    Penn MS
    Am J Cardiol; 2008 May; 101(10A):30D-33D. PubMed ID: 18474271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloperoxidase-generated oxidants modulate left ventricular remodeling but not infarct size after myocardial infarction.
    Vasilyev N; Williams T; Brennan ML; Unzek S; Zhou X; Heinecke JW; Spitz DR; Topol EJ; Hazen SL; Penn MS
    Circulation; 2005 Nov; 112(18):2812-20. PubMed ID: 16267254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling.
    Naito K; Anzai T; Yoshikawa T; Anzai A; Kaneko H; Kohno T; Takahashi T; Kawamura A; Ogawa S
    J Card Fail; 2008 Dec; 14(10):831-8. PubMed ID: 19041046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.
    Maruyama Y; Lindholm B; Stenvinkel P
    J Nephrol; 2004; 17 Suppl 8():S72-6. PubMed ID: 15599890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction.
    Timmers L; van Keulen JK; Hoefer IE; Meijs MF; van Middelaar B; den Ouden K; van Echteld CJ; Pasterkamp G; de Kleijn DP
    Circ Res; 2009 Mar; 104(5):699-706. PubMed ID: 19168865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Myeloperoxidase as a factor of oxidative damage of the myocardium: inactivation of dihydrolipoamide dehydrogenase].
    Gutiérrez Correa J; Stoppani AO
    Medicina (B Aires); 1998; 58(2):171-8. PubMed ID: 9706251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase and cardiovascular disease.
    Nicholls SJ; Hazen SL
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1102-11. PubMed ID: 15790935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells.
    Maekawa Y; Mizue N; Chan A; Shi Y; Liu Y; Dawood S; Chen M; Dawood F; de Couto G; Li GH; Suzuki N; Yeh WC; Gramolini A; Medin JA; Liu PP
    Circulation; 2009 Oct; 120(14):1401-14. PubMed ID: 19770394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astaxanthin, oxidative stress, inflammation and cardiovascular disease.
    Fassett RG; Coombes JS
    Future Cardiol; 2009 Jul; 5(4):333-42. PubMed ID: 19656058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and left ventricular remodelling after myocardial infarction.
    Hori M; Nishida K
    Cardiovasc Res; 2009 Feb; 81(3):457-64. PubMed ID: 19047340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Astaxanthin: a novel potential treatment for oxidative stress and inflammation in cardiovascular disease.
    Pashkow FJ; Watumull DG; Campbell CL
    Am J Cardiol; 2008 May; 101(10A):58D-68D. PubMed ID: 18474276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo markers of oxidative stress and therapeutic interventions.
    Tsimikas S
    Am J Cardiol; 2008 May; 101(10A):34D-42D. PubMed ID: 18474272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling.
    Kohno T; Anzai T; Naito K; Miyasho T; Okamoto M; Yokota H; Yamada S; Maekawa Y; Takahashi T; Yoshikawa T; Ishizaka A; Ogawa S
    Cardiovasc Res; 2009 Feb; 81(3):565-73. PubMed ID: 18984601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diet with isolated soy protein reduces oxidative stress and preserves ventricular function in rats with myocardial infarction.
    Hagen MK; Lehenbauer-Lüdke AR; Paludo AC; Schenkel P; Gonçalves L; Fernandes TG; Caron R; Llesuy S; Mill JG; Belló-Klein A
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):91-7. PubMed ID: 18571392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin protects myocardium from ischemia-reperfusion injury in hypertensive rats: role of myeloperoxidase activity.
    Sahna E; Deniz E; Bay-Karabulut A; Burma O
    Clin Exp Hypertens; 2008 Oct; 30(7):673-81. PubMed ID: 18855270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The oxidant/antioxidant equilibrium in horses.
    Kirschvink N; de Moffarts B; Lekeux P
    Vet J; 2008 Aug; 177(2):178-91. PubMed ID: 17897849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment.
    Brennan ML; Hazen SL
    Curr Opin Lipidol; 2003 Aug; 14(4):353-9. PubMed ID: 12865732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
    Tsutsui H; Kinugawa S; Matsushima S
    Cardiovasc Res; 2009 Feb; 81(3):449-56. PubMed ID: 18854381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of labile iron pool in cardiovascular diseases.
    Kruszewski M
    Acta Biochim Pol; 2004; 51(2):471-80. PubMed ID: 15218543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.